Vaccines help protect against disease by preparing the body’s immune system to recognize and fight foreign substances, such as bacteria, viruses, or other germs. There are several types of vaccines, which work in different ways to help the body recognize and defend against these germs. One specific type of vaccine, the mRNA vaccine, uses a molecule called messenger RNA (mRNA). mRNA is found in nearly all living things and is necessary for protein production.
mRNA vaccines contain a piece of mRNA that carries instructions for making a protein, or part of a protein, from a germ. mRNA vaccines do not contain the germ itself and cannot cause diseases. After vaccination, cells can use the mRNA to temporarily produce the germ protein. Cells then quickly break down and remove the mRNA. mRNA from vaccines does not enter the cell nucleus and does not alter DNA.
The body’s immune system recognizes the germ protein as foreign, triggering a normal immune response that includes producing specialized proteins called antibodies. Antibodies help protect the body against infection by recognizing individual viruses or other germs, attaching to them, and stopping them from entering the body’s cells. They can also help other immune cells find and destroy the germs. Although antibody levels can decrease over time, immune cells can quickly produce more antibodies if the body is exposed to the same germ later. This immune response helps lower the risk of illness.
Like all vaccines in the United States, mRNA vaccines require authorization or approval from the U.S. Food and Drug Administration (FDA) before they can be used. mRNA vaccines are approved for the prevention and treatment of multiple diseases, including COVID-19, the disease caused by the SARS-CoV-2 coronavirus. Researchers are currently studying whether mRNA vaccines can be used to protect against other diseases.
Scientific journal articles for further reading
Blakney AK, Top KA, Cowling BJ, Larson HJ, Shattock RJ, Sadarangani M. Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective. Lancet. 2026 Jul 18;408(10551):275-288. doi: 10.1016/S0140-6736(26)00512-X. Epub 2026 Jun 30. PMID: 42379196.
Pardi N, Krammer F. mRNA vaccines for infectious diseases - advances, challenges and opportunities. Nat Rev Drug Discov. 2024 Nov;23(11):838-861. doi: 10.1038/s41573-024-01042-y. Epub 2024 Oct 4. PMID: 39367276; PMCID: PMC13101425.
Microscopic image of SARS-CoV-2, the virus that causes COVID-19. Spike proteins are seen surrounding the outer membrane of each virus particle.

Topics in the Gene Therapy and Other Medical Advances chapter
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.